Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Sriman Swarup"'
Publikováno v:
Case Reports in Urology, Vol 2019 (2019)
A 61-year-old obese Caucasian male with past medical history of smoking, hypertension, chronic obstructive pulmonary disease (COPD), and sleep apnea presented to the hematology clinic with polycythemia. Despite the newly-diagnosed polycythemia, the p
Externí odkaz:
https://doaj.org/article/aaa8bd6113274cf59f918c4c5870f18d
Publikováno v:
Journal of Gastrointestinal Cancer. 51:1077-1080
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf5f9f86ff994a643643aa0298bbc0cb
https://doi.org/10.1007/s12029-020-00400-4
https://doi.org/10.1007/s12029-020-00400-4
Autor:
Chhanda Bose, Sahil Tonk, Santosh Chavali, Sanjay Awasthi, Kishore Bhende, Philip Palade, Meenakshi Darden, Ashly Hindle, Tejaswini P. Reddy, Sharda P. Singh, Sriman Swarup, Vijay S. Tonk, Aditya Rajan
Publikováno v:
The Southwest Respiratory and Critical Care Chronicles. 8:7-20
Background: Comparative genomic hybridization (CGH) microarrays are used forgenome-wide evaluation of copy number variations (CNV) of known prognostic significance;however, unannotated variants of uncertain significance (VUS) are frequently present.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cdda0b23913a39f5826cd5b706018fa
https://doi.org/10.12746/swrccc.v8i33.627
https://doi.org/10.12746/swrccc.v8i33.627
Publikováno v:
Thrombosis Research. 196:75-77
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39e9a8fd2baf34617ee353acc5a57af5
https://doi.org/10.1016/j.thromres.2020.08.009
https://doi.org/10.1016/j.thromres.2020.08.009
Autor:
Miguel Quirch, Yin Mon Myat, Catherine Jones, Anita Sultan, Somedeb Ball, Sriman Swarup, Kyaw Zin Thein, Rachana Yendala, Myo H. Zaw
Publikováno v:
Journal of the National Comprehensive Cancer Network. 17:CLO19-059
Background: Pain, fatigue, hot flushes, and rash significantly contribute to quality of life in breast cancer patients undergoing chemotherapy. Hormone receptor-positive breast cancer is a common entity among women worldwide. In cancer cells, CDK4/6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe12a5390656c962f72b12283cece7e7
https://doi.org/10.6004/jnccn.2018.7234
https://doi.org/10.6004/jnccn.2018.7234
Autor:
Zayar M. Oo, Miguel Quirch, Nyein H. Yu, Donald P. Quick, Sriman Swarup, Kyaw Zin Thein, Anita Sultan, Wai Lin Thein, Myo H. Zaw
Publikováno v:
Journal of the National Comprehensive Cancer Network. 17:EPR19-071
Background: Bruton’s tyrosine kinase (BTK) is essential for signaling of B-cell and chemokine receptors. Ibrutinib targets BTK and has become frontier in many hematologic malignancies. We undertook systematic review and pooled analysis of randomize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc921d36fd892699fb9b96507d7c3e8e
https://doi.org/10.6004/jnccn.2018.7151
https://doi.org/10.6004/jnccn.2018.7151
Autor:
Somedeb Ball, Myo H. Zaw, Anita Sultan, Catherine Jones, Sriman Swarup, Fred Hardwicke, Kyaw Zin Thein, Sanjay Awasthi, Lukman Tijani
Publikováno v:
Journal of the National Comprehensive Cancer Network. 17:CLO19-052
Introduction: Ribociclib, a cyclin-dependent kinase 4/6 inhibitor, has improved survival in patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER 2)-negative advanced breast cancer. Despite remarkable efficacy, p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f081d82ab489a3027a79a92dcbee4807
https://doi.org/10.6004/jnccn.2018.7154
https://doi.org/10.6004/jnccn.2018.7154
Autor:
Sriman Swarup, Nimesh Adhikari, Anita Sultan, Myo Zaw, Ye Aung, Kyaw Zin Thein, Yin Mon Myat, Nusrat Jahan, Upama Sharma
Publikováno v:
Journal of the National Comprehensive Cancer Network. 17:CLO19-050
Background: VEGFR, KIT, RET, and MET pathways are implicated in several solid tumors. Cabozantinib is an oral inhibitor of these kinase pathways, and hence has found its use in treatment of multiple malignancies. However, it has several side effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47360a58d2ea8083b38fd60961221fef
https://doi.org/10.6004/jnccn.2018.7150
https://doi.org/10.6004/jnccn.2018.7150
Autor:
Kyaw Zin Thein, Anita Sultan, Ye Aung, Sriman Swarup, Meily Arevalo, Miguel Quirch, Somedeb Ball, Myo H. Zaw, Yin Mon Myat
Publikováno v:
Journal of the National Comprehensive Cancer Network. 17:EPR19-73
Background: CDK4 and CDK6 are cyclin-dependent kinases that control transition between G1 and S phases of the cell cycle, hence controlling cell cycle progression by reversible combination with cyclin D1. In cancer cell, CDK4/6 activity is overexpres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4999556a7441ebd1858b9322e1f4bc9a
https://doi.org/10.6004/jnccn.2018.7153
https://doi.org/10.6004/jnccn.2018.7153
Autor:
Yin Mon Myat, Somedeb Ball, Nimesh Adhikari, Catherine Jones, Anita Sultan, Sriman Swarup, Kyaw Zin Thein, Myo H. Zaw, Francis Mogollon-Duffo
Publikováno v:
Journal of the National Comprehensive Cancer Network. 17:CLO19-051
Background: Breast cancer is the most common cancer in women, and the majority of breast cancers express the estrogen receptor or progesterone receptor. Inhibition of CDK4/6 signaling pathway has shown survival benefit in advanced breast cancer by ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4b0b4bbc0fbf3cefb2dea7c939c61ca
https://doi.org/10.6004/jnccn.2018.7152
https://doi.org/10.6004/jnccn.2018.7152